KRW 11870.0
(-2.63%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 697.79 Million KRW | -1.97% |
2022 | 711.81 Million KRW | 18.86% |
2021 | 598.88 Million KRW | -70.06% |
2020 | 2 Billion KRW | -86.67% |
2019 | 15 Billion KRW | 0.0% |
2018 | - KRW | 0.0% |
2017 | - KRW | -100.0% |
2016 | 31.69 Million KRW | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 709.99 Million KRW | -12.91% |
2024 Q1 | 815.23 Million KRW | 16.83% |
2023 Q2 | 351.1 Million KRW | -34.24% |
2023 Q4 | 697.79 Million KRW | 185.18% |
2023 Q3 | 244.68 Million KRW | -30.31% |
2023 Q1 | 533.88 Million KRW | -25.0% |
2023 FY | 697.79 Million KRW | -1.97% |
2022 Q4 | 711.81 Million KRW | -21.64% |
2022 Q3 | 908.41 Million KRW | -15.35% |
2022 Q2 | 1.07 Billion KRW | -13.55% |
2022 Q1 | 1.24 Billion KRW | 107.27% |
2021 Q4 | 598.88 Million KRW | 498.89% |
2021 Q3 | 100 Million KRW | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
InBody Co.,Ltd | 6.08 Billion KRW | 88.524% |
Curexo Inc. | 2.05 Billion KRW | 66.116% |
Seegene, Inc. | 141.76 Billion KRW | 99.508% |
i-SENS, Inc. | 143.79 Billion KRW | 99.515% |
Ray Co., Ltd. | 86.67 Billion KRW | 99.195% |
Gencurix Inc. | 17.95 Billion KRW | 96.114% |
Sugentech Inc. | 15.3 Billion KRW | 95.44% |
L&C Bio Co., Ltd | 82.13 Billion KRW | 99.15% |